Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?33.12
 
WKN: A2AP32 / Symbol: PTGX / Name: Protagonist / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Protagonist Therapeutics Inc Stock

We see a rather positive sentiment for Protagonist Therapeutics Inc with 6 Buy predictions and 2 Sell predictions.
With a target price of 33 € there is a hugely positive potential of 51.38% for Protagonist Therapeutics Inc compared to the current price of 21.8 €.
So far the community has only identified positive things for Protagonist Therapeutics Inc stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Protagonist Therapeutics Inc in the next few years

Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -
Target price 34.133
Change
Ends at 28.02.25

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at JPMorgan Chase & Co. from $34.00 to $37.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 35.089
Change
Ends at 28.02.25

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 30.157
Change
Ends at 30.10.24

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $32.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Show more